All In MedTech

Device Trial Radar · NCT01506401

The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial

The Oscillation for ARDS Treated Early (OSCILLATE) Trial

Last checked: Nov 20, 2026Latest source record: Aug 6, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 548 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

548

Actual

Start

Jun 2009

Primary completion

Sep 2012

Study completion Sep 2012

Sponsor

Lead sponsor
Canadian Critical Care Trials GroupAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Canadian Institutes of Health Research (CIHR); McMaster University; University of Toronto
First posted
Jan 10, 2012

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 16 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

What is the effect of early high frequency oscillation (HFO) versus a lung-protective conventional ventilation (CV) strategy (using HFO only as rescue therapy), on all-cause hospital mortality among patients with severe early acute respiratory distress syndrome (ARDS)?

Conditions

  • Acute Respiratory Distress Syndrome (ARDS)

Interventions

  • SensorMedics 3100B High Frequency Oscillatory VentilatorDevice

    High Frequency Oscillation

  • Lung Protective VentilationProcedure

    Tidal Volume 6ml/kg; plateau pressure \< or = 35cmH20; Prescribed PEEP/FiO2 chart

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. All-cause hospital mortalityTime frame: Randomised patients will be ventilated according to their assigned ventilation strategy for up to 60 days, until they die on the ventilator or are successfully (for >24 hours) liberated from mechanical ventilation.

Locations

38 sites in 5 countries. Site status is shown where the registry gives one.

  • Denver Health Medical Centre

    Denver, Colorado

  • Orlando Regional Medical Centre

    Orlando, Florida

  • University of Michigan

    Ann Arbor, Michigan

35 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.